Act as Internalist π¨π»ββοΈπ«π©Ί
Open in Telegram
Ψ±Ψ§Ψ¨Ψ· ΩΩΨ§Ψ© Ψ§ΩΨ¬Ψ±Ψ§ΨΨ© https://t.me/Clinicalsurgeryround Ψ±Ψ§Ψ¨Ψ· ΩΩΨ§Ψ© Ψ§ΩΨ§Ψ·ΩΨ§Ω https://t.me/Clinicalpediatricround Ψ±Ψ§Ψ¨Ψ· ΩΩΨ§Ψ© Ψ§ΩΨΉΩΩΩ https://t.me/Clinicalophthalomlogy Ψ±Ψ§Ψ¨Ψ· ΩΩΨ§Ψ© Ψ§ΩΨ£Ψ΄ΨΉΨ© https://t.me/Radiolologymodules Ψ±Ψ§Ψ¨Ψ· ΩΩΨ§Ψ© Ψ§Ω ENT https://t.me/ENTclinical
Show moreThe country is not specifiedThe category is not specified
250
Subscribers
No data24 hours
+37 days
+330 days
Posts Archive
β€οΈ INTERNAL MEDICINE β HEART FAILURE
PART 3: DIFFERENTIAL DIAGNOSIS OF DYSPNEA
ββββββββββββββββββ
1. MAIN CATEGORIES β
CARDIAC
- Heart failure
- IHD/ACS
- Arrhythmias
- Valvular disease
- Cardiomyopathy
- Pericardial disease
RESPIRATORY
- Asthma
- COPD
- Pneumonia
- Pulmonary embolism
- Pneumothorax
- Pleural effusion
- ILD
HEMATOLOGICAL
- Anemia
METABOLIC
- Metabolic acidosis
- DKA
- Sepsis
PSYCHOGENIC
- Anxiety/panic
ββββββββββββββββββ
2. HEART FAILURE
Features favoring HF:
- Dyspnea
- Orthopnea
- PND
- Bilateral pitting edema
- Raised JVP
- Bibasal crackles
- S3
- Hepatomegaly
- Weight gain
ββββββββββββββββββ
3. ASTHMA
- Episodic dyspnea
- Wheezing
- Chest tightness
- Cough
- Trigger-related symptoms
- Atopy
β οΈ Severe HF may also cause wheeze (βcardiac asthmaβ).
ββββββββββββββββββ
4. COPD
- Chronic progressive dyspnea
- Chronic cough
- Sputum
- Smoking/biomass exposure
- Wheeze
- Prolonged expiration
- Reduced breath sounds
β Smoking + chronic cough/sputum β COPD
ββββββββββββββββββ
5. PNEUMONIA
- Fever
- Cough
- Sputum
- Dyspnea
- Pleuritic chest pain
- Focal crackles/bronchial breathing
β Fever + cough + focal signs β pneumonia
ββββββββββββββββββ
6. PULMONARY EMBOLISM
- Sudden dyspnea
- Pleuritic chest pain
- Tachycardia
- Hypoxemia
- Β± Hemoptysis
- Β± Syncope
Risk factors:
- Surgery
- Immobilization
- Previous DVT/PE
- Cancer
- Pregnancy/postpartum
- Estrogen therapy
ββββββββββββββββββ
7. PNEUMOTHORAX
- Sudden dyspnea
- Sudden unilateral chest pain
- Reduced/absent breath sounds
- Hyperresonance
β οΈ Tension pneumothorax = emergency.
ββββββββββββββββββ
8. ANEMIA
β Hb β β oxygen carrying capacity β tissue hypoxia β compensatory response β exertional dyspnea.
Clues:
- Pallor
- Fatigue
- Tachycardia
- Low Hb
ββββββββββββββββββ
9. METABOLIC ACIDOSIS
Deep + rapid breathing = Kussmaul respiration
Causes:
- DKA
- Renal failure
- Lactic acidosis
- Severe sepsis
ββββββββββββββββββ
10. RAPID COMPARISON βββ
Diagnosis| Key clue
HF| Orthopnea + PND + edema + βJVP
Asthma| Episodic wheeze + triggers
COPD| Chronic cough/sputum + smoking
Pneumonia| Fever + cough + focal signs
PE| Sudden dyspnea + pleuritic pain
Pneumothorax| Sudden unilateral pain + absent breath sounds
Anemia| Pallor + fatigue + low Hb
Acidosis| Kussmaul breathing
π₯ DYSPNEA IS A SYMPTOM, NOT A DIAGNOSIS.
β€οΈ INTERNAL MEDICINE β HEART FAILURE
PART 2: DYSPNEA, ORTHOPNEA & PND β HISTORY AND ANALYSIS
ββββββββββββββββββ
1. DYSPNEA
Dyspnea = an uncomfortable awareness or sensation of difficult breathing.
In HF:
LV dysfunction β β LV filling pressure β β pulmonary venous pressure β pulmonary congestion β Dyspnea
ββββββββββββββββββ
2. ANALYSIS OF DYSPNEA βββ
Use:
O-D-C-S-A-R-A
O β Onset
- Sudden or gradual?
- What was the patient doing?
D β Duration
- Hours, days, weeks or months?
C β Course
- Progressive?
- Stable?
- Intermittent?
- Acute deterioration on chronic dyspnea?
S β Severity
- What distance can the patient walk?
- Can they climb stairs?
- Does it occur with ordinary activity?
- Minimal activity?
- At rest?
A β Aggravating factors
- Exertion
- Walking
- Stairs
- Lying flat
- Night-time
R β Relieving factors
- Rest
- Sitting upright
- Standing
- Several pillows
- Diuretics
A β Associated symptoms
- Orthopnea
- PND
- Cough
- Frothy sputum
- Wheeze
- Edema
- Chest pain
- Palpitations
- Syncope
- Fatigue
ββββββββββββββββββ
3. ORTHOPNEA βββ
Definition:
Dyspnea occurring when lying flat and relieved by sitting or standing.
Mechanism:
Lying flat
β
β Venous return
β
β Pulmonary venous pressure
β
Pulmonary congestion
β
Dyspnea
Ask:
Β«βHow many pillows do you use to sleep?βΒ»
ββββββββββββββββββ
4. PND βββ
Paroxysmal Nocturnal Dyspnea
Sudden severe breathlessness that awakens the patient from sleep.
Mechanism:
Recumbency + fluid redistribution
β
β Venous return
β
β Pulmonary congestion
β
Sudden nocturnal dyspnea
β Orthopnea: occurs on lying flat.
β PND: wakes the patient from sleep.
ββββββββββββββββββ
5. FUNCTIONAL LIMITATION
Mild: Heavy exertion.
Moderate: Ordinary walking/stairs.
Severe: Minimal activity such as dressing/bathing.
Very severe: At rest.
Correlate with NYHA class.
ββββββββββββββββββ
π₯ VIVA
Q: How do you analyze dyspnea?
A: Onset, duration, course, severity, aggravating factors, relieving factors and associated symptoms.
Q: What is orthopnea?
A: Dyspnea on lying flat relieved by sitting/standing.
Q: What is PND?
A: Sudden nocturnal dyspnea that awakens the patient from sleep.
Q: Why does orthopnea occur?
A: Increased venous return in the supine position raises pulmonary venous pressure and causes pulmonary congestion.
ββββββββββββββββββ
π§ GOLDEN FORMULA
WHEN? β HOW? β HOW SEVERE? β WHAT WORSENS IT? β WHAT RELIEVES IT? β WHAT IS ASSOCIATED?
β Never write βdyspneaβ alone in a long case. Analyze it.
β€οΈ INTERNAL MEDICINE β HEART FAILURE
PART 1: DEFINITION, CLASSIFICATION & CLINICAL PRESENTATION
ββββββββββββββββββ
1. DEFINITION βββ
Heart Failure (HF) is a clinical syndrome caused by a structural and/or functional abnormality of the heart, resulting in:
β Cardiac output and/or β intracardiac pressures
leading to symptoms and signs caused by:
- Pulmonary/systemic congestion
- Inadequate tissue perfusion
π§ Simple concept:
Cardiac dysfunction β β Output Β± β Filling pressure β Congestion + Poor perfusion
β HF = Low output + Congestion
ββββββββββββββββββ
2. MAIN CONSEQUENCES
A. β CARDIAC OUTPUT
β β Tissue perfusion
Features:
- Fatigue
- Weakness
- Reduced exercise tolerance
- Dizziness
- Cold extremities
- Confusion in severe cases
- Reduced renal perfusion β oliguria
B. β FILLING PRESSURES / CONGESTION
Pulmonary congestion:
- Dyspnea
- Orthopnea
- PND
- Cough
- Crackles
- Pulmonary edema
- Frothy sputum
Systemic congestion:
- Raised JVP
- Peripheral edema
- Hepatomegaly
- Ascites
- Weight gain
ββββββββββββββββββ
3. CLASSIFICATION ACCORDING TO EF βββ
HFrEF: LVEF β€40%
HFmrEF: LVEF 41β49%
HFpEF: LVEF β₯50% + evidence supporting increased filling pressures/structural heart disease.
π§ 40 / 41β49 / 50
ββββββββββββββββββ
4. ACCORDING TO TIME COURSE
Acute HF
β New onset or rapid worsening.
Chronic HF
β Established/persistent HF.
Acute decompensated HF
β Acute worsening of pre-existing HF.
ββββββββββββββββββ
5. ACCORDING TO PREDOMINANT SIDE
Left HF
β Mainly pulmonary congestion.
Right HF
β Mainly systemic venous congestion.
β οΈ Both frequently coexist.
ββββββββββββββββββ
6. NYHA FUNCTIONAL CLASSIFICATION βββ
Class| Functional limitation
I| No limitation of ordinary activity
II| Slight limitation; ordinary activity causes symptoms
III| Marked limitation; less-than-ordinary activity causes symptoms
IV| Symptoms at rest
π§ I = None β II = Ordinary β III = Less β IV = Rest
ββββββββββββββββββ
7. CLINICAL PRESENTATION βββ
Respiratory:
- Exertional dyspnea
- Orthopnea
- PND
- Nocturnal cough
- Wheeze
- Frothy sputum
Low output:
- Fatigue
- Weakness
- Reduced exercise tolerance
- Dizziness
- Reduced urine output
Fluid retention:
- Bilateral leg edema
- Rapid weight gain
- Abdominal distension
Cardiac:
- Palpitations
- Chest pain
- Syncope
ββββββββββββββββββ
8. IMPORTANT SIGNS
- Tachycardia
- Raised JVP
- Displaced apex beat
- S3 gallop
- Cardiac murmurs
- Bibasal crackles
- Pleural effusion
- Hepatomegaly
- Ascites
- Bilateral pitting edema
ββββββββββββββββββ
π₯ HIGH-YIELD VIVA
Q: Define HF.
A: A clinical syndrome caused by structural and/or functional cardiac abnormality resulting in reduced cardiac output and/or increased intracardiac pressures, producing symptoms and signs of congestion and/or inadequate perfusion.
Q: What are the major consequences?
A: Reduced cardiac output and increased filling pressures/congestion.
Q: What are the NYHA classes?
A: I no limitation, II slight limitation, III marked limitation, IV symptoms at rest.
ββββββββββββββββββ
π§ MASTER MEMORY
LOW OUTPUT β Fatigue + Weakness + β Exercise tolerance
PULMONARY CONGESTION β Dyspnea + Orthopnea + PND + Crackles
SYSTEMIC CONGESTION β β JVP + Edema + Hepatomegaly + Ascites
π₯ HEART FAILURE = β OUTPUT + β CONGESTION
Q9. What is the treatment principle of CML?
β‘οΈ BCR-ABL1 tyrosine kinase inhibition with TKIs.
Q10. Does every patient with CLL need treatment?
β‘οΈ No. Asymptomatic early CLL may be managed by observation.
Q11. What is Richter transformation?
β‘οΈ Transformation of CLL into an aggressive lymphoma, most commonly DLBCL.
Q12. What is the most important emergency in suspected APL?
β‘οΈ Coagulopathy/DIC; start ATRA urgently.
Q13. What are the classic laboratory findings of tumor lysis syndrome?
β‘οΈ βKβΊ, βuric acid, βphosphate, βCaΒ²βΊ and acute kidney injury.
Q14. What is leukostasis?
β‘οΈ Symptomatic hyperleukocytosis causing microvascular obstruction, especially in the lungs and CNS.
ββββββββββββββββββ
β LEUKEMIA β ONE-LINE MAP
LEUKEMIA
β
Acute β ALL / AML
Chronic β CLL / CML
ALL β Child + CNS + lymphoid
AML β Auer rods + myeloid + gum hypertrophy
CML β BCR-ABL1 + basophilia + massive spleen
CLL β B-cell + CD5/CD23 + smudge cells
APL β DIC β ATRA
Marrow failure β Anemia + Infection + Bleeding
π©Έ LEUKEMIA β PART 8/8
π Complications + Final Comparison + High-Yield Viva
ββββββββββββββββββ
π΄ 1. MAJOR COMPLICATIONS OF LEUKEMIA
A. Bone Marrow Failure
Replacement of normal marrow β
β’ Anemia β pallor, fatigue, dyspnea
β’ Neutropenia β recurrent/severe infections
β’ Thrombocytopenia β petechiae, bruising, bleeding
β Marrow failure = Anemia + Infection + Bleeding
ββββββββββββββββββ
B. Infection
Causes:
β’ Neutropenia
β’ Abnormal leukocyte function
β’ Impaired immunity
β’ Hypogammaglobulinemia, especially in CLL
Common manifestations:
β’ Fever
β’ Pneumonia
β’ Sepsis
β’ Recurrent infections
β οΈ Fever + severe neutropenia = medical emergency.
ββββββββββββββββββ
C. Bleeding
Main causes:
β’ Thrombocytopenia
β’ Platelet dysfunction
β’ DIC, particularly in APL
Clinical features:
β’ Petechiae
β’ Purpura
β’ Epistaxis
β’ Gum bleeding
β’ Menorrhagia
β’ GI bleeding
β’ Severe cases β intracranial bleeding
ββββββββββββββββββ
D. Leukostasis
Usually associated with marked hyperleukocytosis, particularly acute leukemia.
Important organs:
π« Lungs β dyspnea, hypoxia
π§ Brain β headache, confusion, neurological deficits
β οΈ It is an emergency requiring rapid cytoreduction.
ββββββββββββββββββ
E. Tumor Lysis Syndrome
May occur spontaneously or after starting treatment.
Laboratory findings:
β Uric acid
β Potassium
β Phosphate
β Calcium
β Creatinine
β‘οΈ May cause acute kidney injury, arrhythmias and seizures.
Prevention/management:
β’ Adequate hydration
β’ Allopurinol
β’ Rasburicase when indicated
β’ Close monitoring of electrolytes and renal function
ββββββββββββββββββ
F. CNS Involvement
Especially important in ALL.
May cause:
β’ Headache
β’ Vomiting
β’ Cranial nerve palsies
β’ Meningeal symptoms
β’ Seizures
β Therefore, CNS-directed therapy/prophylaxis is an important component of ALL treatment.
ββββββββββββββββββ
G. DIC
Particularly associated with:
β Acute Promyelocytic Leukemia (APL)
Clinical features:
β’ Bleeding
β’ Petechiae/ecchymoses
β’ Mucosal bleeding
β’ Thrombosis may also occur
β οΈ Suspected APL β start ATRA urgently.
ββββββββββββββββββ
π₯ FINAL COMPARISON
Feature| ALL| AML| CML| CLL
Cell| Lymphoblast| Myeloblast| Myeloid cells| Mature B cells
Course| Acute| Acute| Chronic| Chronic
Typical age| Children| Adults| Adults| Older adults
Lymphadenopathy| Common| Less prominent| Usually less| Common
Splenomegaly| Common| Variable| Massive| Common
CNS involvement| Important| Possible| Less common| Uncommon
Mediastinal mass| T-ALL| No| No| No
Auer rods| No| Yes| No| No
BCR-ABL1| Some cases| No| Yes| No
Smudge cells| No| No| No| Yes
Main treatment principle| Multiagent chemotherapy + CNS therapy| Induction + consolidation| TKI| Observe if asymptomatic / targeted therapy when indicated
ββββββββββββββββββ
π§ THE 10 MOST IMPORTANT LEUKEMIA CLUES
1οΈβ£ Child + leukemia β ALL
2οΈβ£ Adolescent male + mediastinal mass β T-ALL
3οΈβ£ Auer rods β AML
4οΈβ£ Gum hypertrophy β Monocytic AML
5οΈβ£ APL + DIC β PML-RARA β ATRA
6οΈβ£ Massive splenomegaly + basophilia β CML
7οΈβ£ CML β Philadelphia chromosome β BCR-ABL1 β TKI
8οΈβ£ Older adult + lymphocytosis + smudge cells β CLL
9οΈβ£ CLL + CD5 + CD23 β CLL
π CLL + rapidly enlarging lymph nodes + B symptoms β Richter transformation
ββββββββββββββββββ
π― FINAL VIVA
Q1. Define leukemia.
β‘οΈ A malignant clonal disorder of hematopoietic cells characterized by abnormal proliferation and accumulation of leukocytes or their precursors.
Q2. Classify leukemia.
β‘οΈ According to lineage: myeloid or lymphoid.
According to course: acute or chronic.
Q3. Name the four major types.
β‘οΈ ALL, AML, CLL and CML.
Q4. What causes anemia in leukemia?
β‘οΈ Bone marrow replacement/failure with reduced normal erythropoiesis.
Q5. Why does leukemia cause recurrent infection?
β‘οΈ Neutropenia and/or dysfunctional leukocytes.
Q6. Why does leukemia cause bleeding?
β‘οΈ Mainly thrombocytopenia due to marrow failure.
Q7. What are Auer rods?
β‘οΈ Needle-like azurophilic cytoplasmic inclusions in myeloid blasts; strongly support AML.
Q8. What is the Philadelphia chromosome?
β‘οΈ t(9;22) producing the BCR-ABL1 fusion gene.
π©Έ LEUKEMIA β PART 7/8
π Management of Chronic Leukemia + Complications
ββββββββββββββββββ
πΉ 1. CML β MANAGEMENT
The main treatment is:
β Tyrosine Kinase Inhibitors (TKIs)
Examples:
β’ Imatinib
β’ Dasatinib
β’ Nilotinib
β’ Bosutinib
These target the BCR-ABL1 tyrosine kinase.
Treatment Response Monitoring
Monitor:
β’ CBC
β’ BCR-ABL1 molecular response
β’ Clinical response
β’ Spleen size
ββββββββββββββββββ
πΉ WHEN IS STEM-CELL TRANSPLANT CONSIDERED IN CML?
Consider in selected patients with:
β’ TKI-resistant disease
β’ TKI-intolerant disease with inadequate alternatives
β’ Advanced/blast-phase disease
β’ Certain high-risk situations
β Modern treatment has made transplantation less common as first-line therapy.
ββββββββββββββββββ
πΉ CML BLAST CRISIS
CML may progress from:
Chronic phase β Accelerated phase β Blast phase
Blast phase resembles acute leukemia.
Clinical features may include:
β’ Increasing anemia
β’ Fever
β’ Bleeding
β’ Bone pain
β’ Increasing splenomegaly
β’ Rising blast percentage
β Treatment usually requires intensive leukemia therapy + TKI, with transplantation considered in eligible patients.
ββββββββββββββββββ
πΉ 2. CLL β MANAGEMENT
Not every patient with CLL requires immediate treatment.
β Asymptomatic early-stage CLL β observation (βwatch and waitβ).
Treatment is started when there is clinically significant or progressive disease.
Indications for Treatment
β’ Progressive symptomatic lymphadenopathy
β’ Progressive splenomegaly
β’ Significant/progressive anemia
β’ Significant/progressive thrombocytopenia
β’ Rapidly increasing lymphocyte count in the appropriate clinical context
β’ Constitutional symptoms:
β Fever
β Night sweats
β Weight loss
β Severe fatigue
ββββββββββββββββββ
πΉ MODERN CLL THERAPY
Common targeted approaches include:
β’ BTK inhibitors
β’ BCL-2 inhibitorβbased therapy
β’ Anti-CD20 monoclonal antibodies in selected regimens
Examples include:
Ibrutinib / Acalabrutinib / Zanubrutinib
and
Venetoclax
β Choice depends on patient factors and molecular risk.
ββββββββββββββββββ
πΉ 3. IMPORTANT CLL COMPLICATIONS
A. Recurrent Infections
Due to:
β Hypogammaglobulinemia + impaired immune function
Management may include:
β’ Vaccination
β’ Prompt treatment of infections
β’ Immunoglobulin replacement in selected patients with recurrent serious infections
B. Autoimmune Hemolytic Anemia
May cause:
β’ Jaundice
β’ Falling Hb
β’ β Reticulocytes
β’ β Unconjugated bilirubin
β’ β Haptoglobin
C. Immune Thrombocytopenia
β Bleeding and low platelet count.
ββββββββββββββββββ
πΉ 4. RICHTER TRANSFORMATION
Definition:
Transformation of CLL into an aggressive lymphoma.
Most commonly:
β Diffuse large B-cell lymphoma (DLBCL)
Clinical Clues
A patient with CLL develops:
β’ Rapidly enlarging lymph nodes
β’ Fever
β’ Night sweats
β’ Weight loss
β’ Rapid clinical deterioration
β’ Rising LDH
β οΈ Think Richter transformation.
ββββββββββββββββββ
πΉ 5. LEUKEMIA EMERGENCIES
π¨ Febrile Neutropenia
Fever + severe neutropenia.
β‘οΈ Medical emergency
π¨ Tumor Lysis Syndrome
β’ β KβΊ
β’ β Uric acid
β’ β Phosphate
β’ β CaΒ²βΊ
β’ Acute kidney injury
π¨ Leukostasis
Very high leukocyte count with impaired microcirculation.
Possible:
β’ Respiratory distress
β’ Neurological symptoms
β’ Confusion
β’ Headache
π¨ DIC in APL
Bleeding and thrombosis may occur.
β Suspected APL β start ATRA urgently.
ββββββββββββββββββ
π§ HIGH-YIELD MEMORY
CML β BCR-ABL1 β TKI
CLL β observe if asymptomatic
CLL + rapidly growing nodes + B symptoms β Richter transformation
Fever + neutropenia β Emergency
APL + DIC β ATRA urgently
ββββββββββββββββββ
π― VIVA QUESTIONS
Q: First-line principle of CML treatment?
β‘οΈ Tyrosine kinase inhibitor targeting BCR-ABL1.
Q: Does every CLL patient need immediate treatment?
β‘οΈ No. Asymptomatic early disease can be observed.
Q: What is Richter transformation?
β‘οΈ Transformation of CLL into an aggressive lymphoma, most commonly DLBCL.
Q: What is leukostasis?
β‘οΈ Symptomatic hyperleukocytosis causing impaired microvascular perfusion, especially affecting the lungs and CNS.
π©Έ LEUKEMIA β PART 6/8
π Management of Acute Leukemia
ββββββββββββββββββ
πΉ GENERAL PRINCIPLES
Management depends on:
β’ Type of leukemia
β’ Age and general condition
β’ Genetic/molecular abnormalities
β’ Risk stratification
β’ CNS involvement
β’ Response to treatment
Main goals:
β Achieve complete remission
β Prevent relapse
β Treat complications
β Maintain long-term disease control
ββββββββββββββββββ
πΉ 1. SUPPORTIVE MANAGEMENT
Blood Products
β’ Packed RBCs β symptomatic/severe anemia
β’ Platelet transfusion β significant thrombocytopenia/bleeding according to clinical indication
Infection Management
β’ Prompt assessment of fever
β’ Blood cultures when appropriate
β’ Broad-spectrum antibiotics for febrile neutropenia
Tumor Lysis Prevention
β’ Adequate hydration
β’ Monitor electrolytes, renal function and uric acid
β’ Allopurinol or rasburicase when indicated
ββββββββββββββββββ
πΉ 2. AML MANAGEMENT
Treatment usually consists of:
Induction Therapy
Goal β achieve complete remission.
A common intensive approach includes:
Cytarabine + an anthracycline
β Often referred to as β7+3β in suitable patients.
Consolidation
Given after remission to eliminate residual leukemic cells.
β’ High-dose cytarabine in selected patients
β’ Stem-cell transplantation in selected high-risk patients
ββββββββββββββββββ
πΉ 3. APL MANAGEMENT
β οΈ Medical emergency
Because of the high risk of severe bleeding/DIC:
β Start ATRA immediately when APL is strongly suspected, without waiting for final confirmation.
Treatment may include:
β’ ATRA
β’ Arsenic trioxide
β’ Chemotherapy in selected risk groups
Supportive correction of coagulopathy is essential.
ββββββββββββββββββ
πΉ 4. ALL MANAGEMENT
ALL requires multi-agent chemotherapy.
Main phases:
1οΈβ£ Induction
β Achieve remission.
2οΈβ£ Consolidation/Intensification
β Eradicate residual disease.
3οΈβ£ Maintenance
β Prevent relapse.
4οΈβ£ CNS-directed Therapy
β Intrathecal chemotherapy is an important component.
ββββββββββββββββββ
πΉ 5. CNS PROPHYLAXIS
Because leukemic cells can enter the CNS:
β’ Intrathecal methotrexate
β’ Intrathecal cytarabine
β’ Other protocol-based CNS-directed treatment
β Particularly important in ALL.
ββββββββββββββββββ
πΉ 6. STEM-CELL TRANSPLANTATION
May be considered in selected patients with:
β’ High-risk disease
β’ Relapsed leukemia
β’ Refractory disease
β’ Certain unfavorable genetic features
Decision depends on disease type, response, risk and patient fitness.
ββββββββββββββββββ
πΉ IMPORTANT COMPLICATIONS DURING TREATMENT
Tumor Lysis Syndrome
Rapid destruction of leukemic cells causes:
β’ β Uric acid
β’ β Potassium
β’ β Phosphate
β’ β Calcium
β’ Acute kidney injury
β Hyperkalemia and acute kidney injury can be life-threatening.
Febrile Neutropenia
Fever in a severely neutropenic patient is an oncological emergency.
β‘οΈ Requires urgent antimicrobial management.
ββββββββββββββββββ
π§ HIGH-YIELD MEMORY
AML β Induction β Consolidation Β± Transplant
ALL β Induction β Consolidation β Maintenance + CNS therapy
APL β ATRA immediately if suspected
Febrile neutropenia β Emergency
Tumor lysis β Hydration + uric-acid-lowering therapy when indicated
ββββββββββββββββββ
π― VIVA QUESTIONS
Q: What is the main goal of induction therapy?
β‘οΈ Achieve complete remission.
Q: What is the classical AML induction regimen?
β‘οΈ Cytarabine + anthracycline (β7+3β) in suitable patients.
Q: What is the key drug in APL?
β‘οΈ ATRA
Q: Why is CNS-directed therapy important in ALL?
β‘οΈ Because the CNS can act as a sanctuary site for leukemic cells.
Q: What are the major metabolic abnormalities in tumor lysis syndrome?
β‘οΈ Hyperuricemia, hyperkalemia, hyperphosphatemia and hypocalcemia.
π©Έ LEUKEMIA β PART 5/8
π Chronic Leukemia β CML & CLL
ββββββββββββββββββ
πΉ CHRONIC LEUKEMIA
Usually has a slower course with a predominance of more mature cells.
Main types:
1οΈβ£ CML β Chronic Myeloid Leukemia
2οΈβ£ CLL β Chronic Lymphocytic Leukemia
ββββββββββββββββββ
πΉ 1. CHRONIC MYELOID LEUKEMIA (CML)
A myeloproliferative neoplasm characterized by clonal proliferation of myeloid cells.
β Strongly associated with:
Philadelphia chromosome β t(9;22)
β‘οΈ Produces the BCR-ABL1 fusion gene
β‘οΈ Causes constitutive tyrosine kinase activity
ββββββββββββββββββ
Clinical Features of CML
β’ May be asymptomatic and discovered incidentally
β’ Fatigue
β’ Weight loss
β’ Fever/night sweats
β’ Early satiety
β’ Abdominal discomfort/fullness
β’ Massive splenomegaly
β Massive splenomegaly + marked leukocytosis β think CML.
ββββββββββββββββββ
CBC / Blood Film
β’ Marked leukocytosis
β’ Increased granulocytes at different stages of maturation
β’ Basophilia
β’ Eosinophilia may occur
β’ Anemia may develop
β’ Platelets may be increased
β Basophilia is an important clue to CML.
ββββββββββββββββββ
Diagnosis
β’ CBC + differential
β’ Peripheral blood film
β’ BCR-ABL1 testing
β’ Bone marrow examination when indicated
β’ Cytogenetic/molecular studies
ββββββββββββββββββ
Treatment
β Tyrosine kinase inhibitors (TKIs) are the cornerstone.
Examples:
β’ Imatinib
β’ Dasatinib
β’ Nilotinib
Advanced/refractory disease may require other therapies, including stem-cell transplantation in selected patients.
ββββββββββββββββββ
πΉ CML PHASES
1οΈβ£ Chronic Phase
β’ Most patients present here
β’ Relatively stable disease
2οΈβ£ Accelerated Phase
β’ Increasing leukocytosis/blasts
β’ Worsening disease control
β’ Increasing splenomegaly
3οΈβ£ Blast Phase
β Transformation into an acute leukemia-like phase.
ββββββββββββββββββ
πΉ 2. CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
A clonal malignancy of mature B lymphocytes.
β It is the most common leukemia in many Western adult populations.
ββββββββββββββββββ
Clinical Features of CLL
β’ Often asymptomatic initially
β’ Persistent lymphocytosis
β’ Painless lymphadenopathy
β’ Splenomegaly
β’ Hepatomegaly
β’ Recurrent infections
β’ Fatigue
β’ Weight loss/night sweats in advanced disease
ββββββββββββββββββ
CBC / Blood Film
β’ Persistent absolute lymphocytosis
β’ Anemia may occur
β’ Thrombocytopenia may occur in advanced disease
β Smudge cells may be seen on peripheral blood film.
ββββββββββββββββββ
Immunophenotype
Typical CLL cells express:
β’ CD5
β’ CD19
β’ CD20
β’ CD23
β Co-expression of CD5 + CD23 on B cells is a classic clue.
ββββββββββββββββββ
Important Complications
β’ Recurrent infections
β’ Hypogammaglobulinemia
β’ Autoimmune hemolytic anemia
β’ Immune thrombocytopenia
β’ Secondary malignancies
β’ Richter transformation β aggressive lymphoma
ββββββββββββββββββ
πΉ CML vs CLL
Feature| CML| CLL
Lineage| Myeloid| B-lymphoid
Main blood finding| Granulocytosis| Lymphocytosis
Philadelphia chromosome| β| β
BCR-ABL1| β| β
Basophilia| Common| Not typical
Smudge cells| β| β
Massive splenomegaly| Common| May occur
Main treatment| TKIs| Depends on stage/biology
ββββββββββββββββββ
π§ HIGH-YIELD MEMORY
CML β βBCR-ABL + Basophilia + Big Spleenβ
CLL β βB-cell + CD5/CD23 + Smudge cells + Lymphocytosisβ
ββββββββββββββββββ
π― VIVA QUESTIONS
Q: What is the Philadelphia chromosome?
β‘οΈ t(9;22) producing BCR-ABL1.
Q: Which leukemia is associated with massive splenomegaly and basophilia?
β‘οΈ CML
Q: What are smudge cells?
β‘οΈ Fragile lymphocytes that rupture during preparation of the blood film; classically seen in CLL.
Q: What is Richter transformation?
β‘οΈ Transformation of CLL into an aggressive lymphoma, most commonly diffuse large B-cell lymphoma.
π©Έ LEUKEMIA β PART 4/8
π Acute Leukemia β ALL & AML
ββββββββββββββββββ
πΉ ACUTE LEUKEMIA
Definition:
A rapidly progressive malignant disorder characterized by accumulation of immature blast cells in the bone marrow and/or blood.
Main types:
1οΈβ£ ALL β Acute Lymphoblastic Leukemia
2οΈβ£ AML β Acute Myeloid Leukemia
ββββββββββββββββββ
πΉ 1. ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Malignant proliferation of lymphoid precursor cells.
Common Features
β’ More common in children
β’ Fever
β’ Pallor
β’ Recurrent infections
β’ Bleeding/bruising
β’ Bone or joint pain
β’ Lymphadenopathy
β’ Hepatosplenomegaly
β’ CNS involvement
β’ Testicular involvement
ββββββββββββββββββ
Important ALL Subtypes
B-ALL
β’ Most common type of ALL
β’ Common in childhood
T-ALL
β’ More common in adolescent males
β’ May present with a mediastinal mass
β Mediastinal mass + acute leukemia β think T-ALL.
ββββββββββββββββββ
πΉ ALL β CNS INVOLVEMENT
Leukemic cells may infiltrate the CNS.
Possible features:
β’ Headache
β’ Vomiting
β’ Cranial nerve palsies
β’ Meningeal irritation
β’ Seizures
β CNS evaluation and prophylaxis are important components of ALL treatment.
ββββββββββββββββββ
πΉ 2. ACUTE MYELOID LEUKEMIA (AML)
Malignant proliferation of myeloid precursor cells.
Common Features
β’ Fatigue/pallor
β’ Fever
β’ Recurrent infections
β’ Bleeding
β’ Bone pain
β’ Hepatosplenomegaly
β’ Lymphadenopathy may occur
ββββββββββββββββββ
πΉ IMPORTANT AML CLUES
Auer Rods
β Needle-shaped cytoplasmic inclusions in myeloid blasts.
β‘οΈ Strongly support myeloid differentiation.
Gum Hypertrophy
Particularly associated with monocytic AML.
Myeloid Sarcoma
Extramedullary collection of myeloid blasts.
ββββββββββββββββββ
πΉ ACUTE PROMYELOCYTIC LEUKEMIA (APL)
A special subtype of AML.
Associated with:
β t(15;17) β PML-RARA fusion
Major clinical concern:
β οΈ Disseminated intravascular coagulation (DIC)
Therefore, suspected APL is a medical emergency.
Treatment
β ATRA (all-trans retinoic acid) is central to treatment.
ββββββββββββββββββ
πΉ ALL vs AML
Feature| ALL| AML
Cell lineage| Lymphoid| Myeloid
Common age| Children| Mainly adults
Bone pain| Common| May occur
Lymphadenopathy| Common| Less prominent
CNS involvement| Common| Less common
Mediastinal mass| T-ALL| Uncommon
Auer rods| β| β
Gum hypertrophy| Less typical| AML, especially monocytic
DIC| Less typical| APL
ββββββββββββββββββ
π§ HIGH-YIELD MEMORY
Child + leukemia β ALL
Adolescent male + mediastinal mass β T-ALL
Auer rods β AML
Gum hypertrophy β Monocytic AML
APL + bleeding/DIC β Think PML-RARA β ATRA
ββββββββββββββββββ
π― VIVA QUESTIONS
Q: What are the two major types of acute leukemia?
β‘οΈ ALL and AML
Q: Which acute leukemia is commonest in children?
β‘οΈ ALL
Q: Which leukemia may present with a mediastinal mass?
β‘οΈ T-ALL
Q: What are Auer rods?
β‘οΈ Cytoplasmic inclusions in myeloid blasts, strongly supporting AML.
Q: Which AML subtype is associated with DIC?
β‘οΈ Acute promyelocytic leukemia (APL).
Q: What is the characteristic genetic abnormality of APL?
β‘οΈ t(15;17), PML-RARA.
π©Έ LEUKEMIA β PART 3/8
π Investigations & Diagnosis
ββββββββββββββββββ
πΉ 1. COMPLETE BLOOD COUNT (CBC)
May show:
β’ β Hemoglobin β anemia
β’ β Platelets β thrombocytopenia
β’ WBC β, normal, or β
β’ Abnormal differential count
β’ Neutropenia may occur
β’ Blasts may be present
β Remember: A normal or low WBC count does not exclude acute leukemia.
ββββββββββββββββββ
πΉ 2. PERIPHERAL BLOOD FILM
Look for:
β’ Blast cells
β’ Abnormal lymphocytes/myeloid cells
β’ Anemia
β’ Thrombocytopenia
β’ Neutropenia
β’ Abnormal RBC morphology
β Auer rods β strongly suggest AML.
ββββββββββββββββββ
πΉ 3. BONE MARROW ASPIRATION & BIOPSY
β Essential investigation for diagnosis and classification.
Assess:
β’ Cellular morphology
β’ Blast percentage
β’ Myeloid vs lymphoid lineage
β’ Marrow cellularity
β’ Dysplasia/infiltration
Acute leukemia: typically β₯20% blasts in blood or bone marrow, with specific genetic exceptions.
ββββββββββββββββββ
πΉ 4. FLOW CYTOMETRY
Used to determine the lineage and immunophenotype of leukemic cells.
Helps distinguish:
β’ B-ALL
β’ T-ALL
β’ AML
β’ Other hematological neoplasms
ββββββββββββββββββ
πΉ 5. CYTOGENETIC & MOLECULAR TESTING
Used to identify important chromosomal/genetic abnormalities.
Examples:
β’ BCR-ABL1 β CML and some ALL
β’ PML-RARA β Acute promyelocytic leukemia (APL)
β’ Other mutations/translocations β classification, prognosis and treatment selection
ββββββββββββββββββ
πΉ 6. BIOCHEMISTRY
Check:
β’ Renal function
β’ Liver function
β’ Electrolytes
β’ Uric acid
β’ LDH
β’ Calcium
β’ Phosphate
β High uric acid + high LDH may indicate high tumor burden.
ββββββββββββββββββ
πΉ 7. COAGULATION PROFILE
Especially important if APL is suspected.
Check:
β’ PT
β’ aPTT
β’ Fibrinogen
β’ D-dimer
β οΈ APL can cause DIC, which is a medical emergency.
ββββββββββββββββββ
πΉ 8. OTHER INVESTIGATIONS
According to clinical presentation:
β’ Chest X-ray
β’ ECG/echocardiography before certain chemotherapy
β’ Infection screening
β’ Blood cultures if febrile
β’ Lumbar puncture when indicated, especially for CNS assessment in ALL
ββββββββββββββββββ
π§ DIAGNOSTIC APPROACH
Suspected leukemia
β¬οΈ
CBC + Peripheral blood film
β¬οΈ
Bone marrow examination
β¬οΈ
Flow cytometry
β¬οΈ
Cytogenetic + molecular studies
β¬οΈ
Final diagnosis + risk classification
ββββββββββββββββββ
π― HIGH-YIELD VIVA
Q: Most important test to establish acute leukemia?
β‘οΈ Bone marrow examination with immunophenotyping.
Q: What are Auer rods?
β‘οΈ Needle-shaped cytoplasmic inclusions in myeloid blasts, strongly associated with AML.
Q: Which leukemia is associated with BCR-ABL1?
β‘οΈ CML and a subset of ALL.
Q: Which leukemia is strongly associated with DIC?
β‘οΈ Acute promyelocytic leukemia (APL).
π©Έ LEUKEMIA β PART 2/8
π Clinical Examination & Why
ββββββββββββββββββ
πΉ 1. GENERAL EXAMINATION
Look for:
β’ General condition
β’ Pallor
β’ Fever
β’ Jaundice
β’ Petechiae/purpura
β’ Ecchymosis/bruising
β’ Bone tenderness
β’ Lymphadenopathy
β’ Hepatomegaly
β’ Splenomegaly
β’ Signs of infection
Vital Signs
β’ Temperature
β’ Pulse
β’ Blood pressure
β’ Respiratory rate
β’ SpOβ
ββββββββββββββββββ
πΉ 2. PALLOR
Why?
β Due to anemia from bone marrow failure/replacement.
Common sites:
β’ Lower palpebral conjunctiva
β’ Tongue/oral mucosa
β’ Palms
β’ Nail beds
ββββββββββββββββββ
πΉ 3. BLEEDING SIGNS
Look for:
β’ Petechiae
β’ Purpura
β’ Ecchymosis
β’ Epistaxis
β’ Gum bleeding
β’ Retinal hemorrhage
Why?
β Thrombocytopenia caused by impaired marrow production.
ββββββββββββββββββ
πΉ 4. LYMPH NODES
Examine:
β’ Cervical
β’ Axillary
β’ Epitrochlear
β’ Inguinal
Assess:
β’ Site
β’ Size
β’ Number
β’ Tenderness
β’ Consistency
β’ Mobility
β’ Matting
β Usually painless lymphadenopathy suggests leukemic/lymphoid infiltration.
ββββββββββββββββββ
πΉ 5. ABDOMINAL EXAMINATION
Look for:
Splenomegaly
Why?
β Leukemic infiltration
β Extramedullary hematopoiesis
Hepatomegaly
Why?
β Leukemic infiltration.
Assess:
β’ Size
β’ Surface
β’ Consistency
β’ Tenderness
ββββββββββββββββββ
πΉ 6. BONE EXAMINATION
Check for:
β’ Sternal tenderness
β’ Long-bone tenderness
β’ Joint tenderness
Why?
β Leukemic infiltration and expansion of bone marrow.
β Sternal tenderness is an important clue in acute leukemia.
ββββββββββββββββββ
πΉ 7. SKIN & MUCOUS MEMBRANES
Look for:
β’ Petechiae
β’ Purpura
β’ Ecchymosis
β’ Pallor
β’ Infections
β’ Gum hypertrophy
β Gum hypertrophy β particularly associated with AML, especially monocytic subtypes.
ββββββββββββββββββ
πΉ 8. RESPIRATORY & CARDIOVASCULAR
Look for:
β’ Tachycardia
β’ Flow murmur
β’ Dyspnea
β’ Signs of infection
β’ Pleural effusion if clinically suspected
Why?
Anemia β tachycardia/flow murmur.
Infection or leukemic infiltration β respiratory complications.
ββββββββββββββββββ
πΉ 9. NEUROLOGICAL EXAMINATION
Assess:
β’ Higher mental functions
β’ Cranial nerves
β’ Motor system
β’ Sensory system
β’ Reflexes
Why?
Some leukemias, especially ALL, can involve the CNS.
Possible manifestations:
β’ Headache
β’ Vomiting
β’ Cranial nerve palsies
β’ Meningeal signs
β’ Seizures
ββββββββββββββββββ
πΉ 10. TESTICULAR EXAMINATION
Particularly important in ALL, especially in children.
Why?
The testes can act as a sanctuary site for leukemic cells.
ββββββββββββββββββ
π§ EXAMINATION MEMORY
Think:
LEUKEMIA = 5 BIG SIGNS
π©Έ Pallor β Anemia
π¦ Fever/Infection β Neutropenia
π©Έ Bleeding β Thrombocytopenia
π΅ Lymphadenopathy β Infiltration
π« Hepatosplenomegaly β Infiltration
β Bone tenderness β marrow infiltration
ββββββββββββββββββ
π― VIVA QUESTION
Q: Why does leukemia cause anemia, infection and bleeding?
A: Because leukemic cells replace the normal bone marrow, causing:
β RBC production β Anemia
β Normal WBC/neutrophil production β Infection
β Platelet production β Bleeding
π©Έ LEUKEMIA β PART 1/8
π Long Case History & Clinical Presentation
ββββββββββββββββββ
πΉ 1. DEFINITION
Q: What is leukemia?
A:
Leukemia is a malignant clonal disorder of hematopoietic cells, characterized by uncontrolled proliferation and accumulation of abnormal leukocytes or their precursors in the bone marrow, with possible involvement of peripheral blood and other tissues.
ββββββββββββββββββ
πΉ 2. CLASSIFICATION
Leukemia is classified according to the cell lineage and rate of progression:
According to cell lineage:
β’ Myeloid
β’ Lymphoid
According to clinical course:
β’ Acute β rapid progression, predominance of immature blast cells
β’ Chronic β slower progression, more mature cells
β Therefore, the major types are:
1οΈβ£ ALL β Acute Lymphoblastic Leukemia
2οΈβ£ AML β Acute Myeloid Leukemia
3οΈβ£ CLL β Chronic Lymphocytic Leukemia
4οΈβ£ CML β Chronic Myeloid Leukemia
ββββββββββββββββββ
πΉ 3. CHIEF COMPLAINTS
A patient with leukemia may present with:
β’ Fatigue and generalized weakness
β’ Fever
β’ Recurrent infections
β’ Easy bruising or bleeding
β’ Bone/joint pain
β’ Weight loss
β’ Lymph node enlargement
β’ Abdominal distension/fullness due to hepatosplenomegaly
ββββββββββββββββββ
πΉ 4. HISTORY OF PRESENTING ILLNESS
The patient was apparently well until _, when they developed progressive generalized weakness and easy fatigability, associated with fever and recurrent infections.
The patient also noticed easy bruising and spontaneous bleeding, such as epistaxis or gum bleeding.
There may be associated bone or joint pain, particularly in acute leukemia.
The patient may report loss of appetite and weight loss, together with painless swelling of lymph nodes and abdominal fullness due to hepatosplenomegaly.
ββββββββββββββββββ
πΉ 5. IMPORTANT HISTORY QUESTIONS
π©Έ A. Anemia Symptoms
Ask about:
β’ Fatigue
β’ Weakness
β’ Dizziness
β’ Dyspnea
β’ Palpitations
β‘οΈ Why?
Due to reduced RBC production and anemia.
π¦ B. Infection
Ask about:
β’ Fever
β’ Recurrent infections
β’ Sore throat
β’ Oral ulcers
β’ Cough
β’ Urinary symptoms
β‘οΈ Why?
Abnormal leukocytes and neutropenia β impaired immunity.
π©Έ C. Bleeding
Ask about:
β’ Epistaxis
β’ Gum bleeding
β’ Petechiae
β’ Purpura
β’ Hematuria
β’ Melena
β’ Hematemesis
β’ Menorrhagia
β‘οΈ Why?
Thrombocytopenia due to bone marrow replacement.
𦴠D. Bone Symptoms
Ask about:
β’ Bone pain
β’ Joint pain
β’ Sternal tenderness
β‘οΈ Why?
Bone marrow expansion/infiltration.
βοΈ E. Constitutional Symptoms
Ask about:
β’ Weight loss
β’ Loss of appetite
β’ Fever
β’ Night sweats
β‘οΈ Why?
Suggests systemic malignant disease.
π΅ F. Lymphadenopathy
Ask about:
β’ Neck swelling
β’ Axillary swelling
β’ Inguinal swelling
β‘οΈ Why?
Leukemic infiltration of lymphoid tissue.
π« G. Hepatosplenomegaly
Ask about:
β’ Abdominal fullness
β’ Early satiety
β’ Left/right upper abdominal discomfort
β‘οΈ Why?
Infiltration of the spleen and liver.
ββββββββββββββββββ
πΉ 6. PAST MEDICAL HISTORY
Ask about:
β’ Previous episodes of anemia
β’ Recurrent infections
β’ Bleeding disorders
β’ Previous malignancy
β’ Previous chemotherapy/radiotherapy
β’ Autoimmune diseases
β’ Previous blood transfusions
ββββββββββββββββββ
πΉ 7. DRUG & EXPOSURE HISTORY
Ask about exposure to:
β’ Cytotoxic chemotherapy
β’ Radiotherapy
β’ Benzene
β’ Certain industrial chemicals
β’ Previous medications associated with marrow injury
β Important because some exposures can increase the risk of leukemia or therapy-related myeloid neoplasms.
ββββββββββββββββββ
πΉ 8. FAMILY HISTORY
Ask about:
β’ Similar hematological diseases
β’ Leukemia or lymphoma
β’ Hereditary cancer syndromes
β’ Genetic disorders associated with leukemia
ββββββββββββββββββ
πΉ 9. EXAMINATION CLUES
Think of leukemia when you find:
Pallor + fever/infections + bleeding + lymphadenopathy + hepatosplenomegaly Β± bone tenderness
ββββββββββββββββββ
π§ HIGH-YIELD MEMORY
LEUKEMIA = βMARROW FAILURE + INFILTRATIONβ
π©Έ Marrow failure
β Anemia
β Infection
β Bleeding
𦴠Infiltration
β Bone pain
β Lymphadenopathy
β Hepatosplenomegaly
β Acute leukemia β think BLASTS + rapid symptoms.
π©Έ ANEMIA β PART 8/8
π Hemolytic Anemia, Thalassemia & Sickle Cell
ββββββββββββββββββ
πΉ HEMOLYTIC ANEMIA
Definition:
Anemia caused by premature destruction of RBCs when marrow compensation is insufficient.
Clinical Features
β Classic combination:
Anemia + Jaundice + Splenomegaly
Other features:
β’ Dark urine
β’ Fatigue
β’ Tachycardia
β’ Gallstones in chronic hemolysis
ββββββββββββββββββ
πΉ INVESTIGATIONS OF HEMOLYSIS
β’ Reticulocyte count β
β’ Unconjugated bilirubin β
β’ LDH β
β’ Haptoglobin β
β’ Peripheral blood film
β’ Direct antiglobulin test (DAT/Coombs) when immune hemolysis is suspected
ββββββββββββββββββ
πΉ THALASSEMIA
Inherited disorders of globin-chain synthesis.
Types
β’ Alpha thalassemia
β’ Beta thalassemia
Features
β’ Microcytic hypochromic anemia
β’ Target cells
β’ Hemolysis
β’ Splenomegaly
β’ Bone changes in severe disease
β’ Growth retardation in severe childhood disease
Investigations
β’ CBC
β’ Peripheral film
β’ Iron studies
β’ Hemoglobin electrophoresis/HPLC
β’ Genetic testing when required
β Thalassemia trait: very low MCV with a relatively high/normal RBC count.
ββββββββββββββββββ
πΉ SICKLE CELL DISEASE
Inherited disorder caused by abnormal HbS.
Major Complications
β’ Vaso-occlusive pain crises
β’ Acute chest syndrome
β’ Stroke
β’ Splenic dysfunction
β’ Severe infections
β’ Aplastic crisis
β’ Hemolytic crisis
β’ Splenic sequestration
β’ Leg ulcers
β’ Pigment gallstones
ββββββββββββββββββ
πΉ SICKLE CELL CRISES
1οΈβ£ Vaso-occlusive Crisis
Pain due to microvascular occlusion.
2οΈβ£ Aplastic Crisis
Usually associated with Parvovirus B19.
β Reticulocyte count β.
3οΈβ£ Sequestration Crisis
Sudden pooling of blood, especially in the spleen.
β Acute anemia + splenomegaly + hypovolemia.
4οΈβ£ Hemolytic Crisis
Increased hemolysis β worsening anemia and jaundice.
ββββββββββββββββββ
πΉ SICKLE CELL + INFECTION
Functional asplenia increases susceptibility to encapsulated organisms, especially:
β’ Streptococcus pneumoniae
β’ Haemophilus influenzae
β’ Neisseria meningitidis
β Vaccination and appropriate infection prevention are essential.
ββββββββββββββββββ
πΉ HIGH-YIELD VIVA
Q: Anemia + neurological manifestations?
β‘οΈ Vitamin B12 deficiency
Q: Microcytic anemia + high RBC count?
β‘οΈ Thalassemia
Q: Low ferritin + microcytic anemia?
β‘οΈ Iron deficiency anemia
Q: Anemia + jaundice + splenomegaly?
β‘οΈ Hemolytic anemia
Q: Pancytopenia + hypocellular fatty marrow?
β‘οΈ Aplastic anemia
Q: Ring sideroblasts?
β‘οΈ Sideroblastic anemia
Q: Aplastic crisis in sickle cell disease?
β‘οΈ Parvovirus B19
Q: Important complication of sickle cell disease?
β‘οΈ Acute chest syndrome
ββββββββββββββββββ
π§ FINAL ANEMIA MAP
ANEMIA β MCV
β¬οΈ MICROCYTIC
β Iron deficiency
β Thalassemia
β Chronic disease
β Sideroblastic
β Lead
β‘οΈ NORMOCYTIC
β Acute blood loss
β Hemolysis
β Chronic disease
β CKD
β Aplastic
β¬οΈ MACROCYTIC
β B12
β Folate
β Alcohol/liver disease
β Hypothyroidism
β MDS
β Then check RETICULOCYTE COUNT:
β Retics β blood loss / hemolysis
β Retics β decreased production
ββββββββββββββββββ
π― END OF ANEMIA β 8 PARTS
π 5th-Year Internal Medicine | Viva + Long Case Review
π©Έ ANEMIA β PART 7/8
π Pancytopenia & Aplastic Anemia
ββββββββββββββββββ
πΉ PANCYTOPENIA
Q: What is pancytopenia?
A: Reduction in all three major blood cell lines:
β’ RBCs β β anemia
β’ WBCs β β leukopenia/neutropenia
β’ Platelets β β thrombocytopenia
ββββββββββββββββββ
πΉ CAUSES OF PANCYTOPENIA
Bone Marrow Failure
β’ Aplastic anemia
β’ Myelodysplastic syndrome
Marrow Infiltration
β’ Acute leukemia
β’ Lymphoma
β’ Multiple myeloma
β’ Metastatic malignancy
Nutritional
β’ Vitamin B12 deficiency
β’ Folate deficiency
Increased Destruction/Sequestration
β’ Hypersplenism
β’ Some infections
β’ Autoimmune disorders
ββββββββββββββββββ
πΉ APLASTIC ANEMIA
Bone marrow failure characterized by:
β Pancytopenia + markedly hypocellular bone marrow with fatty replacement.
Causes
Inherited
β’ Fanconi anemia
Acquired
β’ Idiopathic
β’ Drugs/toxins
β’ Radiation
β’ Viral infections
β’ Immune-mediated causes
ββββββββββββββββββ
πΉ CLINICAL FEATURES
π©Έ Anemia
β’ Pallor
β’ Fatigue
β’ Dyspnea
π¦ Neutropenia
β’ Recurrent infections
β’ Fever
π©Έ Thrombocytopenia
β’ Petechiae
β’ Purpura
β’ Gum bleeding
β’ Epistaxis
β Usually no significant splenomegaly in uncomplicated aplastic anemia.
ββββββββββββββββββ
πΉ INVESTIGATIONS
CBC
β’ Hb β
β’ WBC β
β’ Platelets β
β’ Reticulocyte count β
Peripheral Film
β’ Pancytopenia
β’ Usually no blasts
Bone Marrow
β Markedly hypocellular/acellular marrow with fatty replacement.
ββββββββββββββββββ
πΉ SEVERE APLASTIC ANEMIA
Markedly hypocellular marrow plus β₯2 of:
β’ ANC <500/Β΅L
β’ Platelets <20,000/Β΅L
β’ Reticulocytes <20,000/Β΅L
β Very severe: ANC <200/Β΅L.
ββββββββββββββββββ
πΉ ACUTE LEUKEMIA β DIFFERENTIAL
Possible features:
β’ Pallor
β’ Fever/recurrent infections
β’ Bleeding/bruising
β’ Lymphadenopathy
β’ Hepatosplenomegaly
β’ Bone/sternal tenderness
CBC may show:
β’ Anemia
β’ Thrombocytopenia
β’ WBC β, normal, or β
β’ Blasts may be present
β Bone marrow examination is essential for diagnosis.
ββββββββββββββββββ
π§ VIVA PEARL
Pancytopenia + hypocellular fatty marrow β Aplastic anemia
Pancytopenia + blasts β Think acute leukemia
β’ Microcytic or dimorphic anemia
β’ β Serum iron
β’ β Ferritin
β’ β Transferrin saturation
Bone Marrow
β Ring sideroblasts around the nucleus of erythroblasts.
ββββββββββββββββββ
π§ VIVA PEARLS
B12 β anemia + neurological signs
Folate β anemia without neurological signs
Sideroblastic β anemia + iron overload + ring sideroblasts
π©Έ ANEMIA β PART 6/8
π Vitamin B12, Folate & Sideroblastic Anemia
ββββββββββββββββββ
πΉ VITAMIN B12 DEFICIENCY
Causes
β’ Pernicious anemia
β’ Gastrectomy
β’ Ileal disease/resection
β’ Malabsorption
β’ Strict vegan diet
β’ Certain drugs
Clinical Features
Hematological
β’ Macrocytic megaloblastic anemia
β’ Pallor
β’ Fatigue
GIT
β’ Glossitis
β’ Loss of appetite
β’ Weight loss
Neurological
β’ Paresthesia
β’ Numbness
β’ Loss of vibration/proprioception
β’ Ataxia
β’ Gait disturbance
β’ Subacute combined degeneration
β’ Cognitive/psychiatric changes
β Neurological manifestations strongly favor B12 deficiency over folate deficiency.
ββββββββββββββββββ
πΉ PERNICIOUS ANEMIA
An autoimmune disease causing impaired B12 absorption due to intrinsic factor deficiency.
Investigations
β’ Low serum B12
β’ β Methylmalonic acid
β’ β Homocysteine
β’ Anti-intrinsic factor antibodies
β’ Anti-parietal cell antibodies
Treatment
Hydroxocobalamin 1 mg IM initially, followed by maintenance according to the underlying cause and local protocol.
β In pernicious anemia β long-term/lifelong replacement is usually required.
ββββββββββββββββββ
πΉ FOLATE DEFICIENCY
Causes
β’ Poor diet
β’ Alcohol misuse
β’ Malabsorption
β’ Pregnancy/increased requirements
β’ Drugs interfering with folate metabolism
Clinical Features
β’ Megaloblastic anemia
β’ Glossitis
β’ Weakness/fatigue
β No typical neurological manifestations.
ββββββββββββββββββ
β οΈ IMPORTANT
Do not treat suspected B12 deficiency with folic acid alone before excluding B12 deficiency.
Folate may correct the anemia while neurological damage continues.
ββββββββββββββββββ
πΉ SIDEROBLASTIC ANEMIA
Defect in heme synthesis, causing iron accumulation in mitochondria of erythroid precursors.
Causes
β’ Myelodysplastic syndrome
β’ Alcohol
β’ Vitamin B6 deficiency/isoniazid
β’ Lead poisoning
β’ Certain drugs
Blood Findings
β’ Microcytic or dimorphic anemia
β’ β Serum iron
β’ β Ferritin
β’ β Transferrin saturation
Bone Marrow
β Ring sideroblasts around the nucleus of erythroblasts.
ββββββββββββββββββ
π§ VIVA PEARLS
B12 β anemia + neurological signs
Folate β anemia without neurological signs
Sideroblastic β anemia + iron overload + ring sideroblastsπ©Έ ANEMIA β PART 6/8
π Vitamin B12, Folate & Sideroblastic Anemia
ββββββββββββββββββ
πΉ VITAMIN B12 DEFICIENCY
Causes
β’ Pernicious anemia
β’ Gastrectomy
β’ Ileal disease/resection
β’ Malabsorption
β’ Strict vegan diet
β’ Certain drugs
Clinical Features
Hematological
β’ Macrocytic megaloblastic anemia
β’ Pallor
β’ Fatigue
GIT
β’ Glossitis
β’ Loss of appetite
β’ Weight loss
Neurological
β’ Paresthesia
β’ Numbness
β’ Loss of vibration/proprioception
β’ Ataxia
β’ Gait disturbance
β’ Subacute combined degeneration
β’ Cognitive/psychiatric changes
β Neurological manifestations strongly favor B12 deficiency over folate deficiency.
ββββββββββββββββββ
πΉ PERNICIOUS ANEMIA
An autoimmune disease causing impaired B12 absorption due to intrinsic factor deficiency.
Investigations
β’ Low serum B12
β’ β Methylmalonic acid
β’ β Homocysteine
β’ Anti-intrinsic factor antibodies
β’ Anti-parietal cell antibodies
Treatment
Hydroxocobalamin 1 mg IM initially, followed by maintenance according to the underlying cause and local protocol.
β In pernicious anemia β long-term/lifelong replacement is usually required.
ββββββββββββββββββ
πΉ FOLATE DEFICIENCY
Causes
β’ Poor diet
β’ Alcohol misuse
β’ Malabsorption
β’ Pregnancy/increased requirements
β’ Drugs interfering with folate metabolism
Clinical Features
β’ Megaloblastic anemia
β’ Glossitis
β’ Weakness/fatigue
β No typical neurological manifestations.
ββββββββββββββββββ
β οΈ IMPORTANT
Do not treat suspected B12 deficiency with folic acid alone before excluding B12 deficiency.
Folate may correct the anemia while neurological damage continues.
ββββββββββββββββββ
πΉ SIDEROBLASTIC ANEMIA
Defect in heme synthesis, causing iron accumulation in mitochondria of erythroid precursors.
Causes
β’ Myelodysplastic syndrome
β’ Alcohol
β’ Vitamin B6 deficiency/isoniazid
β’ Lead poisoning
β’ Certain drugs
Blood Findings
π©Έ ANEMIA β PART 5/8
π Investigations & Iron Deficiency Anemia
ββββββββββββββββββ
πΉ INVESTIGATIONS IN ANEMIA
1οΈβ£ Complete Blood Count (CBC)
Assess:
β’ Hb
β’ MCV
β’ MCH/MCHC
β’ RBC count
β’ WBC count
β’ Platelet count
β’ RDW
2οΈβ£ Peripheral Blood Film
Look for:
β’ Cell size and shape
β’ Hypochromia
β’ Target cells
β’ Spherocytes
β’ Sickle cells
β’ Schistocytes
β’ Abnormal/immature cells
3οΈβ£ Reticulocyte Count
β High reticulocytes β increased RBC production, usually due to:
β’ Hemolysis
β’ Recent blood loss
β Low reticulocytes β inadequate marrow production.
4οΈβ£ Iron Studies
β’ Serum ferritin
β’ Serum iron
β’ TIBC
β’ Transferrin saturation
5οΈβ£ Vitamin Studies
β’ Serum vitamin B12
β’ Serum folate
6οΈβ£ Other Tests
Depending on suspected cause:
β’ Renal function
β’ Liver function
β’ Thyroid function
β’ ESR/CRP
β’ Hemolysis screen
β’ Bone marrow examination
ββββββββββββββββββ
πΉ IRON DEFICIENCY ANEMIA (IDA)
Causes
1. Increased requirements
β’ Infancy/childhood
β’ Pregnancy
2. Inadequate intake
β’ Poor diet
β’ Malnutrition
3. Malabsorption
β’ Celiac disease
β’ Gastrectomy/bariatric surgery
β’ Intestinal disease
4. Blood loss
β’ Menorrhagia
β’ GI bleeding
β’ Hemorrhoids
β’ GI malignancy
ββββββββββββββββββ
πΉ Clinical Features of IDA
β’ Pallor
β’ Fatigue and weakness
β’ Dyspnea
β’ Palpitations
β’ Headache/dizziness
β’ Glossitis
β’ Angular cheilitis
β’ Koilonychia
β’ Pica
β IDA + koilonychia + angular cheilitis β classic clue.
ββββββββββββββββββ
πΉ IRON STUDIES IN IDA
Test| IDA
Ferritin| β
Serum iron| β
TIBC| β
Transferrin saturation| β
β Low ferritin strongly supports iron deficiency when there is no major inflammatory confounding.
ββββββββββββββββββ
πΉ MENTZER INDEX
Mentzer Index = MCV Γ· RBC count
β’ >13 β favors IDA
β’ <13 β favors Thalassemia
π It is a screening discriminator, not a definitive diagnostic test.
ββββββββββββββββββ
π§ EXAM PEARL
Microcytic anemia β check ferritin first.
If iron deficiency is confirmed, find the cause of iron loss, especially occult GI blood loss in adult men and postmenopausal women.
π©Έ ANEMIA β PART 4/8
π Viva: Microcytic & Macrocytic Anemia
ββββββββββββββββββ
πΉ MICROCYTIC ANEMIA
Q: What is microcytic anemia?
A: Anemia with MCV <80 fL.
Q: What are the main causes?
1οΈβ£ Iron deficiency anemia
2οΈβ£ Thalassemia
3οΈβ£ Anemia of chronic disease
4οΈβ£ Sideroblastic anemia
5οΈβ£ Lead poisoning
ββββββββββββββββββ
πΉ Q: How do you differentiate IDA from Thalassemia?
Feature| IDA| Thalassemia
Hb| β| β
MCV| β| βββ
RBC count| β/normal| β or normal
RDW| β| Usually normal/slightly β
Ferritin| β| Normal/β
Serum iron| β| Normal/β
TIBC| β| Normal
Mentzer index| >13| <13
π§ Mentzer Index = MCV Γ· RBC count
ββββββββββββββββββ
πΉ Q: What is the most common cause of iron deficiency anemia?
A:
β’ In children/women β inadequate intake, increased requirements, or menstrual blood loss.
β’ In adult men and postmenopausal women β chronic gastrointestinal blood loss until proven otherwise.
β Always look for GI malignancy when clinically appropriate.
ββββββββββββββββββ
πΉ MACROCYTIC ANEMIA
Q: What is macrocytic anemia?
A: Anemia with MCV >100 fL.
Causes:
Megaloblastic
β’ Vitamin B12 deficiency
β’ Folate deficiency
β’ Drugs interfering with DNA synthesis
Non-megaloblastic
β’ Alcohol
β’ Liver disease
β’ Hypothyroidism
β’ Reticulocytosis
β’ Myelodysplastic syndromes
ββββββββββββββββββ
πΉ Q: How do you differentiate Vitamin B12 deficiency from Folate deficiency?
Feature| Vitamin B12| Folate
Megaloblastic anemia| β| β
Glossitis| β| β
Neurological manifestations| β| β
Serum B12| β| Normal
Serum folate| Normal/β| β
Homocysteine| β| β
Methylmalonic acid| β| Normal
β Key point:
Neurological manifestations β B12 deficiency.
ββββββββββββββββββ
πΉ Q: What neurological manifestations can occur in B12 deficiency?
β’ Tingling and numbness
β’ Peripheral neuropathy
β’ Loss of vibration sense
β’ Loss of proprioception
β’ Ataxia
β’ Gait disturbance
β’ Subacute combined degeneration
β’ Cognitive/psychiatric changes
ββββββββββββββββββ
π§ VIVA PEARLS
πΈ Microcytic + low ferritin β Iron deficiency
πΈ Very low MCV + high RBC count β Thalassemia
πΈ Macrocytic + neurological signs β B12 deficiency
πΈ Macrocytic without neurological signs β consider Folate deficiency
πΈ Two RBC populations β Dimorphic anemia
ββββββββββββββββββ
π Quick Memory:
MICROCYTIC β βTAILβ
Thalassemia
Anemia of chronic disease
Iron deficiency
Lead/Sideroblastic
MACROCYTIC β βB12 / FOLATE / LIVER / ALCOHOL / THYROID / MDSβ
π©Έ ANEMIA β PART 3/8
π Definition & Classification
ββββββββββββββββββ
πΉ 1. DEFINITION
Q: What is anemia?
A:
Anemia is a reduction in hemoglobin concentration below the normal range for age and sex, usually associated with a reduction in red cell mass.
ββββββββββββββββββ
πΉ 2. ETIOLOGICAL CLASSIFICATION
A. Blood Loss
β’ Acute blood loss β trauma, surgery, GI bleeding.
β’ Chronic blood loss β menorrhagia, GI bleeding, hemorrhoids, etc.
B. Decreased RBC Production
1. Nutritional deficiencies
β’ Iron deficiency
β’ Vitamin B12 deficiency
β’ Folate deficiency
2. Bone marrow failure
β’ Aplastic anemia
β’ Marrow infiltration
3. Chronic disease
β’ Chronic infection/inflammation
β’ Chronic kidney disease
β’ Malignancy
4. Other causes
β’ Hypothyroidism
β’ Sideroblastic anemia
β’ Myelodysplastic disorders
C. Increased RBC Destruction β Hemolytic Anemia
Hereditary
β’ RBC membrane defects β Hereditary spherocytosis
β’ Hemoglobin disorders β Sickle cell disease, Thalassemia
β’ Enzyme defects β G6PD deficiency, Pyruvate kinase deficiency
Acquired
β’ Autoimmune hemolysis
β’ Mechanical hemolysis
β’ Infections
β’ Drugs/toxins
ββββββββββββββββββ
πΉ 3. MORPHOLOGICAL CLASSIFICATION
Based mainly on MCV, MCH and MCHC:
A. Microcytic Hypochromic Anemia
MCV <80 fL
Usually associated with β MCH/MCHC.
Common causes:
β’ Iron deficiency anemia
β’ Thalassemia
β’ Anemia of chronic disease
β’ Sideroblastic anemia
B. Normocytic Normochromic Anemia
Normal MCV and MCHC
Common causes:
β’ Acute blood loss
β’ Hemolytic anemia
β’ Anemia of chronic disease
β’ Chronic kidney disease
β’ Aplastic anemia
C. Macrocytic Anemia
MCV >100 fL
Causes:
β’ Vitamin B12 deficiency
β’ Folate deficiency
β’ Alcohol/liver disease
β’ Hypothyroidism
β’ Drugs
β’ Myelodysplastic disorders
D. Dimorphic Anemia
Presence of two different RBC populations.
Examples:
β’ Iron deficiency + B12 deficiency
β’ Recent blood transfusion
β’ Sideroblastic anemia
ββββββββββββββββββ
π§ HIGH-YIELD MEMORY
Etiological classification = WHY did anemia occur?
Morphological classification = WHAT do the RBCs look like?
β Microcytic β think Iron deficiency / Thalassemia
β Macrocytic + neurological signs β think Vitamin B12 deficiency
β Anemia + jaundice + splenomegaly β think Hemolysis
ββββββββββββββββββ
π Exam Tip:
When given an anemia case, think in this order:
Hb β β MCV β Reticulocyte count β Cause
π©Έ ANEMIA β PART 2/8
CLINICAL EXAMINATION + WHY?
ββββββββββββββββββ
π¨ββοΈ GENERAL EXAMINATION
Assess:
β General appearance
β Pallor
β Degree of anemia
β Jaundice
β Cyanosis
β Clubbing
β Koilonychia
β Leukonychia
β Edema
β Lymphadenopathy
β Thyromegaly
β Sternal tenderness
β Pulse
β Blood pressure
β Temperature
β Respiratory rate
Typical findings in the case:
β Patient looks pale
β Moderately anemic
β No jaundice
β No clubbing
β No cyanosis
β No koilonychia
β No leukonychia
β No edema
β No lymphadenopathy
β No thyromegaly
β No sternal tenderness
β Pulse: 120/min
β BP: 95/65 mmHg
ββββββββββββββββββ
π¨ββοΈ Q: Where do you look for pallor?
Answer:
β Lower palpebral conjunctiva
β Tongue
β Oral mucosa and lips
β Palms and palmar creases
β Nail beds
β Facial skin
ββββββββββββββββββ
π¨ββοΈ Q: Why do you examine the mouth and tongue?
Answer:
β Glossitis β iron deficiency, vitamin B12 or folate deficiency
β Angular cheilitis β commonly iron deficiency
ββββββββββββββββββ
π¨ββοΈ Q: Why do you examine the nails?
Answer:
β Koilonychia β iron deficiency anemia
β Leukonychia may be associated with other systemic/nutritional disorders
ββββββββββββββββββ
π¨ββοΈ Q: Why do you examine the abdomen in a patient with anemia?
Answer:
Mainly to detect:
β Splenomegaly β hemolytic anemia / hypersplenism
β Hepatomegaly β liver disease or other systemic disease
β Viva pearl:
Anemia + jaundice + splenomegaly
β Think hemolytic anemia.
ββββββββββββββββββ
π¨ββοΈ Q: Why do you examine the sternum?
Answer:
To look for sternal tenderness, which may suggest bone marrow disease, especially:
β Acute leukemia
β Multiple myeloma
ββββββββββββββββββ
π¨ββοΈ Q: Why do you examine the neurological system?
Answer:
To detect neurological manifestations of vitamin B12 deficiency, such as:
β Peripheral neuropathy
β Loss of vibration/proprioception
β Ataxia
β Gait disturbance
β Subacute combined degeneration
β Cognitive impairment
β Important:
Anemia + neurological manifestations
β Vitamin B12 deficiency until proven otherwise.
ββββββββββββββββββ
π¨ββοΈ Q: Why do you examine the legs?
Answer:
β Leg ulcers β may occur in sickle cell disease
β Edema β may indicate associated systemic disease
ββββββββββββββββββ
π¨ββοΈ Q: Why do you examine lymph nodes?
Answer:
Lymphadenopathy may suggest:
β Leukemia
β Lymphoma
β Infection
β Malignancy
ββββββββββββββββββ
π¨ββοΈ Q: What clinical findings may point to specific causes?
Iron deficiency anemia:
β Pallor
β Angular cheilitis
β Glossitis
β Koilonychia
Vitamin B12 deficiency:
β Glossitis
β Neurological manifestations
Sickle cell disease:
β Leg ulcers
β Jaundice
β Splenomegaly may depend on age/disease stage
Hemolytic anemia:
β Jaundice
β Splenomegaly
Acute leukemia:
β Pallor
β Fever/infections
β Bleeding
β Lymphadenopathy
β Hepatosplenomegaly
β Bone/sternal tenderness
ββββββββββββββββββ
π¨ββοΈ Q: Can pallor occur without anemia?
Answer:
Yes. Pallor may occur with:
β Shock/vasoconstriction
β Severe systemic illness
β Myxedema
β Lymphedema
β Albinism
β Physiological/racial variation
Therefore, clinical pallor should always be correlated with the CBC.
ββββββββββββββββββ
π©Έ ANEMIA β PART 2/8
